Decreased platelet peripheral-type benzodiazepine receptors in persistently violent schizophrenia patients

Journal of Psychiatric Research

Volumn 37, Issue 6, 2003, Pages 549-556

  Ritsner, Michael ^a,b   Modai, Ilan ^a,b   Gibel, Anatoly ^a   Leschiner, Svetlana ^b   Silver, Henry ^a,b   Tsinovoy, German ^a   Weizman, Abraham ^c,d   Gavish, Moshe ^b  

^a SHA'AR MENASHE MENTAL HEALTH CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c GEHA MENTAL HEALTH CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aggressive behavior; Peripheral type benzodiazepine receptors; Platelet; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE RECEPTOR; CLOTIAPINE; CLOZAPINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; HALOPERIDOL DECANOATE; LEVOMEPROMAZINE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; RISPERIDONE; THROMBOCYTE RECEPTOR; ZUCLOPENTHIXOL; ZUCLOPENTHIXOL ACETATE;

ADULT; AGGRESSION; ANGER; ANXIETY DISORDER; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; EMOTIONAL STRESS; FEMALE; HOSTILITY; HUMAN; MALE; MENTAL DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; RECEPTOR BINDING; SCHIZOPHRENIA; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SUICIDE ATTEMPT; SYMPTOMATOLOGY; THROMBOCYTE MEMBRANE; VOLUNTEER;

EID: 0141992105     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(03)00055-4     Document Type: Article

References (51)

1. Bjork J.M., Moeller F.G., Kramer G.L., Kram M., Suris A., Rush A.J., Petty F. Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorder. Psychiatry Research. 101:2001;131-136.
2. Brown C.S., Kent T.A., Bryant S.G., Gevedon R.M., Campbell J.L., Felthous A.R., Barratt E.S., Rose R.M. Blood platelet uptake of serotonin in episodic aggression. Psychiatry Research. 27:1989;5-12.
3. Brown R.C., Papadopoulos V. Role of the peripheral-type benzodiazepine receptor in adrenal and brain steroidogenesis. International Review of Neurobiology. 46:2001;117-143.
4. Burgin R., Weizman R., Gavish M. Repeated swim stress and peripheral type benzodiazepine receptors. Neutopsychobiology. 33:1996;28-31.
5. Cheung P., Schweitzer I., Crowley K., Tuckwell V. Violence in schizophrenia. role of hallucinations and delusions Schizophrenia Research. 26:1997;181-190.
6. Citrome L., Volavka J. Schizophrenia. violence and comorbidity Current Opinion in Psychiatry. 12:1999;47-51.
7. Coccaro E.F. Impulsive aggression and central serotonergic system function in humans. an example of a dimensional brain-behavior relationship International Clinical Psychopharmacology. 7:1992;3-12.
8. Dmitrieva T.N., Oades R.D., Hauffa B.P., Eggers C. Dehydroepiandrosterone sulphate and corticotropin levels are high in young male patients with conduct disorder. comparisons for growth factors, thyroid and gonadal hormones Neuropsychobiology. 43:2001;134-140.
9. Engel S.R., Grant K.A. Neurosteroids and behavior. International Review of Neurobiology. 46:2001;321-348.
10. Ferrarese C., Appollonio I., Frigo M., Piolti R., Trabucchi M., Frattola L. Decreased density of benzodiazepine receptors in lymphocytes of anxious patients. reversal after chronic diazepam treatment Acta Psychiatrica Scandinavica. 82:1990;169-173.
11. First M., Spitzer R.L., Gibbon M., Williams J.B.W. SCID (DSM-IV) Structured Clinical Interview for Axis I DSM-IV Disorders - Patient Edition (SCID-I/P). 1995;Biometrics Research Department, New York State Psychiatric Institute, New York.
12. Gavish M., Bachman I., Shoukrun R., Katz Y., Veenman L., Weisinger G., Weizman A. Enigma of the peripheral benzodiazepine receptor. Pharmacology Review. 51:1999;629-650.
13. Gavish M., Katz Y., Bar Ami S., Weizman R. Biochemical, physiological, and pathological aspects of the peripheral benzodiazepine receptor. Journal of Neurochemistry. 85:1992;1589-1601.
14. Gavish M., Laor N., Bidder M., Fisher D., Fonia O., Muller U., Reiss A., Wolmer L., Karp L., Weizman R. Altered platelet peripheral-type benzodiazepine receptor in posttraumatic stress disorder. Neuropsychopharmacology. 14:1996;181-186.
15. Gavish M., Weizman A., Karp L., Tyano S., Tanne Z. Decreased peripheral benzodiazepine binding sites in platelets of neuroleptic-treated schizophrenics. European Journal of Pharmacology. 121:1986;275-279.
16. Gavish M., Weizman R. Role of peripheral-type benzodiazepine receptors in steroidogenesis. Clinical Neuropharmacology. 20:1997;473-481.
17. Gerra G., Zaimovic A., Avanzini P., Chittolini B., Giucastro G., Caccavari R., Palladino M., Maestri D., Monica C., Delsignore R., Brambilla F. Neurotransmitter-neuroendocrine responses to experimentally induced aggression in humans. influence of personality variable Psychiatry Research. 66:1997;33-43.
18. Hintze J.L. NCSS 6.0. Statistical System for Windows. User's Guide. 1998;Number Cruncher Statistical Systems, Kaysville Utah.
19. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 13:1987;261-267.
20. Krakowski M., Czobor P., Chou J.C. Course of violence in patients with schizophrenia. relationship to clinical symptoms Schizophrenia Bulletin. 25:1999;505-517.
21. Kurumaji A., Wakai T., Toru M. Decreases in peripheral type benzodiazepine receptors in postmortem brain of chronic schizophrenics. Journal of Neural Transmission. 104:1997;1361. - 1370.
22. Kurumaji A., Nomoto H., Yamada K., Yoshikawa T., Toru M. No association of two missense variations of the benzodiazepine receptor(peripheral) gene and mood disorders in a Japanese sample. American Journal of Medical Genetics. 105:2002;172-175.
23. Kurumaji A., Nomoto H., Yoshikawa T., Okubo Y., Toru M. An association study between two missense variations of the benzodiazepines receptor (peripheral) gene and schizophrenia in a Japanese sample. Journal of Neural Transmission. 107:2000;491-500.
24. Lacor P., Gandolfo P., Tonon M.C., Brault E., Dalibert I., Schumacher M., Benavides J., Ferzaz B. Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration. a role for PBR in neurosteroidogenesis Brain Research. 815:1999;70-80.
25. Linnoila M., Virkkunen M., Scheinin M., Nuutila A., Rimon R., Goodwin F.K. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sciences. 33:1983;2609-2614.
26. McBurnett K., Lahey B.B., Rathouz P.J., Loeber R. Low salivary cortisol and persistent aggression in boys referred for disruptive behavior. Archives of General Psychiatry. 57:2000;38-43.
27. Modai I., Gibel A., Rauchverger B., Ritsner M., Klein E., Ben Shachar D. Paroxetine binding in aggressive schizophrenic patients. Psychiatry Research. 94:2000;77-81.
28. Montgomery S.A., Asberg M. A depression scale designed to be sensitive to change. British Journal of Psychiatry. 134:1979;382-389.
29. Moss H.B., Vanyukov M.M., Martin C.S. Salivary cortisol responses and the risk for substance abuse in prepubertal boys. Biological Psychiatry. 38:1995;547-555.
30. Mullen P.E. Homicide. Current Opinion in Psychiatry. 13:2000;575-579.
31. Nakamura K., Fukunishi I., Nakamoto Y., Iwahashi K., Yoshii M. Peripheral-type benzodiazepine receptors on platelets are correlated with the degrees of anxiety in normal human subjects. Psychopharmacology published online, 14 May. 2002;2002.
32. Nicolas L.B., Pinoteau W., Papot S., Routier S., Guillaumet G., Mortaud S. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice. Brain Research. 922:2001;216-222.
33. Noffsinger S.G., Resnick P.J. Violence and mental illness. Current Opinion in Psychiatry. 12:1999;683-687.
34. Oulis P., Lykouras L., Dascalopoulou E., Psarros C. Aggression among psychiatric inpatients in Greece. Psychopathology. 29:1996;174-180.
35. Pinna G., Dong E., Matsumoto K., Costa E., Guidotti A. In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proceedings of the National Academy of Sciences U S A. 100:2003;2035-2040.
36. Ressler K.J., Nemeroff C.B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety. 12(1):2000;2-19.
37. Ritsner M., Modai I., Endicott J., Rivkin O., Nechamkin Y., Barak P., Goldin V., Ponizovsky A. Differences in quality of life domains, psychopathologic and psychosocial factors in psychiatric patients. Journal of Clinical Psychiatry. 61:2000;880-889.
38. Ritsner M., Modai I., Ponizovsky A. Assessing psychological distress in psychiatric patients. validation of the Talbieh Brief Distress Inventory Comprehensive Psychiatry. 43:2002;229-234.
39. Ritsner M., Rabinowitz J., Slyuzberg M. The Talbieh Brief Distress Inventory. a brief instrument to measure psychological distress among immigrants Comprehensive Psychiatry. 36:1995;1-7.
40. Sakaue M., Ago Y., Murakami C., Sowa C., Sakamoto Y., Koyama Y., Baba A., Matsuda T. Involvement of benzodiazepine binding sites in an antiaggressive effect by 5-HT(1A) receptor activation in isolated mice. European Journal of Pharmacology. 432:2001;163-166.
41. Soreni N., Apter A., Weizman A., Don-Tufeled O., Leschiner S., Karp L., Gavish M. Decreased platelet peripheral-type benzodiazepine receptors in adolescent inpatients with repeated suicide attempts. Biological Psychiatry. 46:1999;484-488.
42. Spielberger C.D., Gorsuch R.K., Luchene R.E. Manual for the state trait anxiety inventory (self-evaluation questionnaire). 1970;Consulting Psychologist Press, Palo Alta, California.
43. Spielberger CD. State-Trait Anger Expression Inventory (STAXI), 1988.
44. Steadman H.J., Mulvey E.P., Monahan J., Robbins P.C., Appelbaum P.S., Grisso T., Roth L.H., Silver E. Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Archives of General Psychiatry. 55:1998;393-401.
45. Tanne Z., Weizman R., Karp L., Katz Y., Tyano S., Gavish M. Lack of effect of 28 days of neuroleptics treatment on platelet benzodiazepines binding sites in schizophrenics. Neuropsychobiology. 17:1987;121-123.
46. van Goozen S.H., Matthys W., Cohen-Kettenis P.T., Thijssen J.H., van Engeland H. Adrenal androgens and aggression in conduct disorder prepubertal boys and normal controls. Biological Psychiatry. 43:1998;156-158.
47. Volavka J. The neurobiology of violence. an update Journal of Neuropsychiatry and Clinical Neuroscience. 11:1999;307-314.
48. Weizman R., Hermesh H., Karp L., Dar D.E., Munitz H., Gavish M. The platelet benzodiazepine receptor is unaltered in obsessive-compulsive disorder. Clinical Neuropharmacology. 16:1993;211-215.
49. Weizman R., Tanne Z., Granek M., Karp L., Golomb M., Tyano S., Gavish M. Peripheral benzodiazepine binding sites on platelet membranes are increased during diazepam treatment of anxious patients. European Journal of Pharmacology. 138:1987;289-292.
50. Weizman R., Tanne Z., Karp L., Tyano S., Gavish M. Peripheral-type benzodiazepine-binding sites in platelets of schizophrenics with and without tardive dyskinesia. Life Science. 39:1986;549-555.
51. Wodarz N., Rothenhofer C., Fischer R., Stober G., Kiehl B., Jungkunz G., Riederer P., Klein H.E. Peripheral-type benzodiazepine receptors in diagnostic subtypes of schizophrenic patients. Psychiatry Research. 81:1998;363-369.